IP Library Granted Patent US 8,940,319
Granted Patent B2
US 8,940,319 · App. 13/486,197 · Granted Jan 27, 2015

Formulations, devices and methods for treating and preventing mucositis

Inventors: Francis E. O'Donnell (Longboat Key, FL); Angelos M. Stergiou (Athens, GR)
Assignee: Accentia Biopharmceuticals, Inc.
A61K9/0043A61K9/0095A61K33/10A61K33/42A61K45/06A61K47/02A61K47/24A61K9/1611A61K9/1617Y10S514/853
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,319
App. No.
13/486,197
Granted
Jan 27, 2015
Kind
B2
Abstract

The present invention is directed to compositions, devices, and methods for non-irritatively treating and preventing mucositis, such as chronic rhinosinusitis (CRS). Some aspects of the invention concern compositions comprising or consisting essentially of sodium phosphate buffer (e.g., sodium phosphate dibasic and sodium phosphate monobasic) and calcium carbonate; mucoadministration devices and kits containing such compositions; and methods for treating or preventing mucositis conditions such as CRS, comprising mucoadministering a composition of the invention to a subject in need thereof.

Claims (19)

1. A kit for treating mucositis, comprising a composition consisting essentially of sodium phosphate buffer and calcium carbonate, and at least one component selected from the group consisting of: a mucoadministration device, a mixing chamber, and a diluent.

2. The kit of claim 1 , wherein said composition is packaged in one or more foil-wrapped sachets.

3. The kit of claim 1 , wherein said composition is a solid.

4. The kit of claim 3 , wherein said solid is a powder.

5. The kit of claim 1 , wherein said composition is a liquid.

6. The kit of claim 1 , wherein the kit comprises said diluent, and wherein said diluent comprises water.

7. The kit of claim 1 , wherein said composition consists essentially of sodium phosphate dibasic, sodium phosphate monobasic, and calcium carbonate.

8. The kit of claim 1 , wherein said composition has about 2% to about 3% (w/w) sodium phosphate buffer and about 0.005 to about 0.030% (w/w) calcium carbonate.

9. The kit of claim 1 , wherein said composition has about 1.59% (w/w) sodium phosphate dibasic, about 0.96% (w/w) sodium phosphate monobasic, and about 0.015% (w/w) calcium carbonate.

10. The kit of claim 1 , wherein said composition does not include any anti-fungal agent.

11. The kit of claim 1 , wherein the kit comprises said mucoadministration device, said mixing chamber, and said diluent.

12. The kit of claim 1 , wherein said mucoadministration device is selected from the group consisting of a nasal pump sprayer, nasal irrigator, syringe, and nebulizer.

13. The kit of claim 1 , wherein the kit comprises said mucoadministration device.

14. The kit of claim 13 , wherein said mucoadministration device is a nasal irrigator.

15. The kit of claim 14 , wherein said nasal irrigator has an outlet portion made of a flexible material, and said outlet portion is adapted to seal a subject's nostril during mucoadministration.

16. The kit of claim 15 , wherein said flexible material is silicone.

17. A kit for treating mucositis, comprising a composition comprising sodium phosphate buffer and calcium carbonate, and at least one component selected from the group consisting of: a nasal irrigator, a mixing chamber, and a diluent, wherein said composition includes no additional active agents.

18. The kit of claim 1 , wherein said composition is a powder packaged in one or more packets or sachets.

19. The kit of claim 17 , wherein said composition is a powder packaged in one or more packets or sachets.

Assignments (1)
CERTIFICATE OF TITLE Recorded Oct 21, 2014
From: ACCENTIA BIOPHARMACEUTICALS, INC.
To: PABETI, INC.
Reel/Frame 034029/0770 →
Continuity (4)
Continuation 12534575 · Aug 3, 2009
Continuation 12417378 · Apr 2, 2009
Provisional Application 61041866 · Apr 2, 2008
Related Publication 20120237618A1 · Sep 20, 2012